HealthInvest Partners’s Revolution Medicines RVMD Stock Holding History

HealthInvest Partners’s Portfolio RVMD Stock Details RVMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$13.7M	Sell	73,077 -544,168	-88%	-$79.5M	3.68%	7
2026 Q1	$9.08M	Buy	617,245 +527,061	+584%	+$53.2M	2.93%	14
2025 Q4	$7.18M	Buy	90,184 +4,829	+6%	+$317K	2.29%	16
2025 Q3	$423K	Buy	85,355 +3,080	+4%	+$121K	1.57%	24
2025 Q2	$3.03M	Buy	82,275 +27,314	+50%	+$1.05M	1.3%	25
2025 Q1	$1.94M	Sell	54,961 -7,200	-12%	-$292K	0.86%	30
2024 Q4	$2.68M	Buy	+62,161	New	+$3.14M	1.27%	24

Other funds holding RVMD

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

DGM

Darwin Global Management St. Helier, Jersey $3.76B AUM 342.13% 1-Year Est. Return

Jupiter Topco New York $245B AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Nextech Invest Zurich, Switzerland $2.11B AUM 413.84% 1-Year Est. Return

PBA

Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return

HealthInvest Partners's RVMD Position: Q2 2026 in Review

HealthInvest Partners reduced its Revolution Medicines (RVMD) stake by 88% in Q2 2026, selling an estimated $79.5M and leaving 73,077 shares worth $13.7M. The position accounts for 3.68% of the portfolio, ranked #7.

HealthInvest Partners first reported a position in RVMD in Q4 2024 and has held it in 7 quarters since. 688 funds tracked by Wall St. Rank hold RVMD as of Q2 2026.

HealthInvest Partners held 73,077 shares of Revolution Medicines worth $13.7M as of Q2 2026.
HealthInvest Partners sold 544,168 Revolution Medicines shares in Q2 2026, an estimated $79.5M.
Revolution Medicines made up 3.68% of HealthInvest Partners's portfolio in Q2 2026, its #7 holding.
HealthInvest Partners first reported a position in Revolution Medicines in Q4 2024 and has held it in 7 quarters since.
688 funds tracked by Wall St. Rank held Revolution Medicines as of Q2 2026.

Based on HealthInvest Partners's 13F filing for Q2 2026, filed 24 Jul 2026.